Please invest in NIH to support the at-risk and hereditary cancer community. Help bring much-needed innovation and research for cancer prevention and early detection. @FacingOurRisk #RallyMedRes #FundNIH @facingourrisk

TAKE 2 MINUTES AND ACT NOW! Join @FacingOurRisk in urging Congress to invest in NIH medical research funding. People with a hereditary predisposition to cancer are at greater risk & may get cancer at younger ages. Increase and #FundNIH. @facingourrisk

RT @MMLynchSyndrome: @FacingOurRisk Lynch previvors have a mutation specific to five genes involved in DNA mismatch repair: MLHL1, MSH2, MS….

RT @MMLynchSyndrome: What is a Previvor?. According to @FacingOurRisk , the meaning of the word "previvor" is a "survivor of a predispositi….

RT @DeMariniFP: Have Hope at the plate. Teaming up with @FacingOurRisk, The Whisper Hope shows support for individuals and families affecte….

RT @DeMariniFP: A FORCE to be reckoned with. The DeMarini Whisper Hope™️ is available now. In collaboration with @FacingOurRisk, the Whispe….

Thank you @Eisai, @Johnson & Johnson & @Pfizer for supporting our 2024 Advocacy Day! Contact your members of Congress & ask them to support key legislation.

Join @Facingourrisk TODAY for its biggest advocacy event! Urge federal lawmakers to support key legislation to ensure affordable, timely access to care & the protection of orphan drug therapies for rare cancers/diseases. #BeaForceofChange #hereditarycancer

We need you! Join @Facingourrisk for its biggest advocacy event of the year! Meet virtually w/members of Congress and their staff to educate them about important issues faced by our high-risk community.

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources.

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources.

We need you! Join @Facingourrisk for its biggest advocacy event of the year! Meet virtually w/members of Congress and their staff to educate them about important issues faced by our high-risk community.

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources.

We need you! Join @Facingourrisk for its biggest advocacy event of the year! Meet virtually w/members of Congress and their staff to educate them about important issues faced by our high-risk community.

Donate #Bitcoin for a cause! Join @FacingOurRisk empowering those at risk of hereditary cancer. Donate BTC today and help further education, support and hope for people facing inherited cancers. #BTC #crypto #cancerawareness.

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources.

Empower those facing hereditary cancer risks! Donate cryptocurrency 🚀 to @FacingOurRisk and join the fight for awareness, education, and support. Together, we can make a difference. #crypto #donate #cancerawareness.

🎉Debbie is our 2024 Teri Woodhull Empowerment Award winner! Her unwavering commitment to the hereditary cancer community is inspiring. Originally from Argentina, Debbie is dedicated to supporting Latino/a communities, bridging gaps in cancer care & research. Congrats, @debsetu!

RT @cure_today: We spoke to Sue Friedman of @FacingOurRisk about the importance of linking patients to clinical trials. .

Men age 18+ with late stage prostate cancer may be eligible for a research study to learn the best dosage of radium and/or the PARP inhibitor Olaparib for treating castration resistant prostate cancer spread to the bones.